Adecoagro SA vs Neurocrine Biosciences Inc — how do they compare? Adecoagro SA trades at $9.67 (market cap $1.36B), while Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 12.1× Adecoagro SA's market cap, and Adecoagro SA pays a 3.15% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| AGRO | NBIX | |
|---|---|---|
Market Cap | $1.36B | $16.46B |
Sector | Technology | Health |
52-Week High | $15.25 | $185.50 |
52-Week Low | $7.13 | $123.10 |
Enterprise Value | $3.39B | $16.48B |
Dividend Yield | 3.15% | — |
Trailing returns across standard periods
Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.
Read more on AGRO →Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →